Simplify Propel Opportuni... (SURI)
NYSEArca: SURI
· 실시간 가격 · USD
18.82
+0.14 (0.75%)
종가 기준: Aug 13, 2026, 3:48 PM
Simplify Propel Opportunities ETF (SURI) ETF Price, Holdings & Analysis
0.75% (1D)
| 매수호가 | 18.74 |
| 시가총액 | n/a |
| 운용자산 | 77.76M |
| 순자산가치 | 18.68 |
| 베타 | 1.15 |
| EPS (최근 12개월) | n/a |
| P/E (최근 12개월) | 31.32 |
| 발행 주식수 | n/a |
| 설정일 | Feb 7, 2023 |
| 매도호가 | 18.89 |
| 거래량 | 3,060 |
| 평균 거래량 (20일) | 2,756 |
| 시가 | 18.70 |
| 전일 종가 | 18.68 |
| 당일 변동폭 | 18.76 - 18.82 |
| 52주 변동폭 | 14.90 - 18.90 |
| 편입 종목 | n/a |
| 총보수 | 2.56% |
SURI 정보
The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.
상위 10종목 자산의 77.16%
| 이름 | 종목코드 | 비중 |
|---|---|---|
| Plains Gp Holdings L... | PAGP | 43.08% |
| Achieve Life Science... | ACHV | 11.82% |
| Milestone Pharmaceut... | MIST | 4.78% |
| Delcath Systems Inc | DCTH | 4.10% |
| Corcept Therapeutics... | CORT | 3.89% |
| Phathom Pharmaceutic... | PHAT | 2.80% |
| Celldex Therapeutics... | CLDX | 2.60% |
| Abeona Therapeutics ... | ABEO | 2.28% |
| Inventiva Sa Adr | IVA | 1.81% |
배당 배당수익률 14.45%
| 배당락일 | 금액 | 지급일 |
|---|---|---|
| Jun 25, 2026 | $0.6800 | n/a |
| Mar 26, 2026 | $0.6800 | n/a |
| Dec 23, 2025 | $0.6800 | n/a |
| Sep 25, 2025 | $0.6800 | n/a |
| Jun 25, 2025 | $0.6800 | n/a |
